GLTO Prakiraan wutah bathi kanggo taun ngarep galecto.com
Galecto, Inc. (GLTO) is developing unique galectin inhibitors to combat cancer and fibrosis, leveraging its patent protection. Shifting analyst estimates for EPS growth visualize this process, with the parameter value reaching -11.90. Future prospects depend on the efficacy of metabolic drugs and strategic partnerships. The company is currently restructuring its pipeline and workforce following unsuccessful tests while maintaining a sufficient liquidity cushion.
GLTO (galecto.com): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Galecto, Inc.|GLTO - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Galecto|GLTO - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Galecto|GLTO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Galecto|Rasio cepet galecto.com
- data bathi resik lan rasio valuasi:
GLTO - Bathi resik|Bathi sing dikarepake Galecto, Inc.|GLTO - Rasio rega marang bathi|Pangali Forward P/E Galecto, Inc.|GLTO - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Galecto|GLTO - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Galecto|GLTO - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan galecto.com|GLTO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Galecto, Inc.
Analisis wiwitan perusahaan:GLTO, Galecto Corp
Galecto, Inc. (GLTO) development of unique selective galectin inhibitors to combat fibrosis defines the trajectory of the consensus EPS n+1 forecast chart, which currently stands at -11.90. This indicator measures the weighted average analyst expectation for earnings per share changes, where a steady upward curve confirms the company's strong pricing power in an inelastic market and market confidence in the future monetization of its drugs.
Analisis perusahaan pesaing
ASND (Ascendis Pharma Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Corp|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (rhythmtx.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Akero AKRO|Metsera, Inc. (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Therapeutics, Inc.|89bio Inc (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agios Pharmaceuticals Inc (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep Structure Corp GPCR|Prakiraan wutah bathi kanggo taun ngarep MDXG (MiMedx Group, Inc.)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep rezolutebio.com|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|MBX - Prakiraan wutah bathi kanggo taun ngarep|Altimmune Corp (ALT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|AARD (Aardvark Pharma) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SGMT (Sagimet Biosciences) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep bioagelabs.com BIOA|Prakiraan wutah bathi kanggo taun ngarep BMEA|Prakiraan wutah bathi saben saham kanggo taun ngarep quincetx.com QNCX|Fractyl - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep VTVT (vTv Therapeutics, Inc.)|ATPC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Pluri Inc.|SYBX (synlogictx.com) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Lipocine Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|MTNB (Matinas BioPharma Holdings, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Spruce Biosciences Inc. (SPRB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Corporation (CTCX)|lumos-pharma.com - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ONVO (Organovo)|RDUS - Prakiraan wutah bathi saben saham kanggo taun ngarep
